mrna stock Surges 8% on Moderna Melanoma Readout and Nasdaq-100 Inclusion: Buy or Top?
MRNA stock jumped 8% on Oct 5, 2026 as Moderna approaches a full melanoma data readout and was confirmed for Nasdaq-100 inclusion effective December 2025...
Enter code for secure login, or use password.
